Patient Management

2074 soru

Tüm türler2,074 Çoktan seçmeli1,048 Çoklu seçim393 Eşleştirme221 Sıralama412

A patient is currently receiving treatment in the cardiovascular step-down unit for a massive pulmonary embolism diagnosed three days ago. She was initially started on an unfractionated heparin infusion. Today, her daily laboratory monitoring reveals a precipitous drop in her platelet count. She has also developed a new, painful, swollen right calf.

Hospital Day	Platelet Count
Day 1 (Admission)	$240,000/\mu L$
Day 2	$215,000/\mu L$
Day 3	$160,000/\mu L$
Day 4 (Today)	$95,000/\mu L$

A serotonin release assay is sent, and a clinical diagnosis of heparin-induced thrombocytopenia (HIT) with a new deep vein thrombosis is suspected.

Arrange the following management and monitoring steps in the correct chronological sequence to appropriately treat this patient's condition and safely transition her to long-term oral anticoagulation with warfarin.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence is to first discontinue heparin, then initiate a direct thrombin inhibitor, monitor platelets until they recover, initiate overlapping warfarin, and finally discontinue the direct thrombin inhibitor once the INR is therapeutic.

The standard of care for heparin-induced thrombocytopenia (HIT) involves immediately discontinuing all heparin products and initiating a non-heparin anticoagulant like argatroban. Transitioning to long-term oral warfarin requires strict monitoring: warfarin cannot be started until the platelet count recovers to at least

150,000/\mu L

. Once started, warfarin must be overlapped with the parenteral anticoagulant for at least 5 days and until the INR is strictly therapeutic (

2.0

3.0

) for 24-48 hours before the parenteral agent can be safely discontinued.

Adım Adım Çözüm

Discontinue unfractionated heparin

Halts further immune complex formation

Heparin is the offending agent causing antibody-mediated platelet activation.

Start argatroban

Provides immediate alternative anticoagulation

Patients with heparin-induced thrombocytopenia have a high risk of new or progressive thrombosis and require ongoing systemic anticoagulation.

Monitor platelet counts

Confirms recovery from the acute consumptive phase

Platelet recovery (typically

\geq 150,000/\mu L

) indicates that the acute prothrombotic state is resolving.

Initiate warfarin

Begins transition to long-term oral therapy

Warfarin can now be safely introduced without the high risk of venous limb gangrene caused by early protein C depletion.

Monitor INR and discontinue argatroban

Completes the transition to monotherapy

Overlap ensures continuous anticoagulation until warfarin fully inhibits vitamin K-dependent clotting factors.

Anahtar Kavram

In patients with heparin-induced thrombocytopenia, warfarin should only be initiated after platelets recover to

\geq 150,000/\mu L

, followed by an overlap period with a non-heparin parenteral anticoagulant until the INR is therapeutic.

Soru 1302Soru →

An established 66-year-old female patient is evaluated in the ambulatory clinic for her annual health maintenance visit. She has no acute complaints and reports feeling well. Her medical history is notable for mild primary hypertension, which is well-controlled on amlodipine. She has never smoked cigarettes and consumes a glass of wine occasionally in social settings. She underwent a normal screening colonoscopy eight years ago and a normal screening mammogram three months ago. A fasting lipid panel performed last year was within normal limits. Her gynecologic history reveals negative cervical cytology and high-risk human papillomavirus (HPV) co-testing at ages 58 and 63, with no history of cervical dysplasia or immunocompromise. Her blood pressure is 124/78 mm Hg, and her body mass index is 23 kg/m². Physical examination is unremarkable. Which of the following is the most appropriate next step in preventive care for this patient?

Perform cervical cytology with high-risk human papillomavirus co-testing

Schedule a screening colonoscopy

Order a low-dose computed tomography scan of the chest

Order a dual-energy x-ray absorptiometry scan

Obtain a screening ultrasound of the abdominal aorta

Cevabı ve açıklamayı göster

Cevap: Order a dual-energy x-ray absorptiometry scan

Cevap

Order a dual-energy x-ray absorptiometry scan

The correct answer identifies that dual-energy x-ray absorptiometry (DEXA) scanning is indicated for this patient. The United States Preventive Services Task Force (USPSTF) Grade B recommendation states that all women 65 years and older should undergo bone measurement testing to screen for osteoporosis. As this patient is 66 years old and has not yet had a DEXA scan, ordering one is the most appropriate next step in her preventive care.

Adım Adım Çözüm

Evaluate the patient's age and sex to identify age-specific screening requirements.

The patient is a 66-year-old female.

Preventive guidelines from the USPSTF are heavily stratified by age and biological sex.

Review the patient's prior screening history to determine if established testing should be continued or discontinued.

She meets the criteria to discontinue cervical cancer screening, and her next colorectal cancer screening is not due for two more years.

Avoiding over-screening is critical. She has adequate prior negative Pap/HPV co-tests within the appropriate timeframes and a normal colonoscopy 8 years ago.

Assess the indication for newly applicable age-based screenings.

Women aged 65 and older require routine osteoporosis screening with a bone measurement test.

Routine screening prevents osteoporotic fractures, and she has crossed the age threshold of 65 without a prior DEXA scan.

Anahtar Kavram

In average-risk women, routine osteoporosis screening with dual-energy x-ray absorptiometry (DEXA) should commence at age 65, while routine cervical cancer screening can be discontinued at age 65 if adequate prior negative screening is documented.

Tahmini Süre:1m 15s

Soru 1303Soru →

A 64-year-old woman comes to the primary care clinic reporting two days of dysuria, urinary frequency, and suprapubic discomfort. She has no fever, flank pain, or vaginal discharge. Her medical history is significant for a mechanical mitral valve replacement, for which she takes chronic warfarin therapy. Her last international normalized ratio (INR) was 3.1 one week ago. She has a documented severe anaphylactic allergy to fluoroquinolones. Vital signs are within normal limits. Urinalysis is positive for leukocyte esterase and nitrites. The physician determines she has an uncomplicated urinary tract infection and plans to prescribe a 3-day course of oral trimethoprim-sulfamethoxazole. Which of the following is the most appropriate pharmacologic management strategy for this patient?

Preemptively reduce the warfarin dose by 25% to 50% and recheck the INR in 3 to 5 days

Continue the current warfarin dose and recheck the INR after completing the antibiotic course

Prescribe oral ciprofloxacin instead of trimethoprim-sulfamethoxazole to avoid altering warfarin metabolism

Administer oral vitamin K concurrently with the antibiotic to stabilize the coagulation cascade

Prescribe empiric oral ampicillin instead of trimethoprim-sulfamethoxazole

Cevabı ve açıklamayı göster

Cevap: Preemptively reduce the warfarin dose by 25% to 50% and recheck the INR in 3 to 5 days

Cevap

Preemptively reduce the warfarin dose by 25% to 50% and recheck the INR in 3 to 5 days

The correct answer accurately identifies the necessary management for a known, severe drug-drug interaction. Trimethoprim-sulfamethoxazole is a potent inhibitor of the cytochrome P450 2C9 (CYP2C9) enzyme, which is responsible for the clearance of S-warfarin (the more pharmacologically active enantiomer). Concurrent administration significantly increases serum warfarin levels and the international normalized ratio (INR), leading to a high risk of bleeding. Because the antibiotic course is short but the interaction is immediate, the standard of care is to preemptively reduce the warfarin dose by 25% to 50% upon initiation of the antibiotic, and to recheck the INR in 3 to 5 days to ensure it remains in the therapeutic range.

Adım Adım Çözüm

Identify the primary diagnosis and intended treatment.

The patient has uncomplicated cystitis, and the physician intends to prescribe trimethoprim-sulfamethoxazole (TMP-SMX).

Establishing the clinical scenario is required before assessing pharmacologic interactions.

Assess potential contraindications to alternative treatments.

The patient has an anaphylactic allergy to fluoroquinolones, ruling out ciprofloxacin or levofloxacin. Ampicillin is also a poor choice due to widespread E. coli resistance.

This confirms that TMP-SMX remains the most appropriate antibiotic choice despite its potential interactions.

Evaluate the pharmacokinetic interaction between TMP-SMX and the patient's chronic medications.

TMP-SMX is a potent inhibitor of CYP2C9, the enzyme responsible for metabolizing the highly active S-enantiomer of warfarin.

Understanding the mechanism of the interaction is critical for predicting its clinical effect (increased INR).

Determine the necessary clinical intervention to mitigate the interaction.

The standard of care is to preemptively reduce the warfarin dose by 25% to 50% and closely monitor the INR within 3 to 5 days.

This maintains therapeutic anticoagulation while preventing life-threatening hemorrhage.

Anahtar Kavram

Pharmacokinetic drug interactions involving warfarin and CYP2C9 inhibitors

Soru 1304Soru →

A 31-year-old woman with a history of myasthenia gravis presents to the emergency department with a two-day history of progressively worsening difficulty swallowing and a weak voice. She states that she recently recovered from a mild upper respiratory infection. Upon evaluation, she is visibly anxious and using accessory neck muscles to breathe. She has a weak, ineffective cough and is unable to clear pooling oropharyngeal secretions. Vital signs are temperature 37.4°C (99.3°F), blood pressure 132/86 mm Hg, pulse 118/min, and respirations 34/min. Oxygen saturation is 87% on room air. Arterial blood gas analysis on room air reveals a pH of 7.28, $\text{pCO}_2$ of 58 mm Hg, and $\text{pO}_2$ of 60 mm Hg. Which of the following is the most appropriate initial step in the management of this patient?

Securing the airway for invasive mechanical ventilation

Initiation of intravenous immunoglobulin therapy

Measurement of forced vital capacity via bedside spirometry

Computed tomography scan of the chest without contrast

Urgent transfer to the medical intensive care unit

Cevabı ve açıklamayı göster

Cevap: Securing the airway for invasive mechanical ventilation

Cevap

The correct answer is securing the airway for invasive mechanical ventilation.

The correct answer, securing the airway for invasive mechanical ventilation, is the absolute immediate priority in this patient. She is in a myasthenic crisis characterized by profound respiratory muscle fatigue (hypoventilation resulting in a

\text{pCO}_2

of 58 mm Hg and severe respiratory acidosis) combined with bulbar weakness. Because she is pooling secretions and has a weak cough, she cannot protect her airway. In this clinical scenario, immediate intubation is the primary stabilization step.

Adım Adım Çözüm

Evaluate the patient's respiratory status, vital signs, and ability to protect the airway.

The patient demonstrates objective signs of impending respiratory failure (respiratory rate 34/min,

\text{pCO}_2

58 mm Hg, pH 7.28) and bulbar weakness (inability to clear pooling secretions).

Identifying the severity of respiratory compromise and airway protection dictates the immediate triage priority (Airway and Breathing).

Determine the most appropriate method of immediate respiratory support.

Invasive mechanical ventilation is prioritized over noninvasive positive pressure ventilation (NIPPV).

Patients with bulbar weakness and an inability to clear oropharyngeal secretions are at an unacceptably high risk of aspiration if NIPPV is used.

Determine the sequence of remaining diagnostic and therapeutic interventions.

Disease-modifying therapies (like IVIG) and diagnostic imaging are deferred until the airway is stabilized.

Definitive treatments take time to act and diagnostic testing requires transporting the patient; neither should delay life-saving stabilization.

Anahtar Kavram

Patients with myasthenic crisis experiencing bulbar weakness, inability to clear secretions, and overt respiratory acidosis require immediate airway securement and invasive mechanical ventilation before any other diagnostic or therapeutic interventions.

Tahmini Süre:1m 15s

Soru 1305Soru →

A 59-year-old woman is evaluated in the intensive care unit shortly after admission for progressive dyspnea, orthopnea, and confusion over the past 48 hours. She has a history of ischemic cardiomyopathy with a left ventricular ejection fraction of 20%, type 2 diabetes mellitus, and chronic kidney disease stage 3. Her home medications include sacubitril-valsartan, metoprolol succinate, spironolactone, dapagliflozin, and oral torsemide.

Vital signs are temperature 36.8°C (98.2°F), blood pressure 82/54 mm Hg, pulse 114/min, and respirations 26/min. Pulse oximetry shows an oxygen saturation of 88% on room air. Physical examination reveals lethargy and confusion. The jugular venous pressure is estimated at 14 cm H2O. Auscultation of the lungs reveals diffuse bilateral crackles extending to the apices. Cardiac examination shows a regular tachycardia with a prominent S3 gallop. The extremities are cool to the touch and mottled, with a capillary refill time of 5 seconds.

Laboratory studies show:
Serum sodium: 132 mEq/L
Serum potassium: 3.3 mEq/L
Serum creatinine: 2.1 mg/dL (baseline 1.5 mg/dL)
B-type natriuretic peptide (BNP): 1,450 pg/mL
High-sensitivity troponin T: 34 ng/L (normal < 14 ng/L)

Electrocardiogram shows sinus tachycardia with a left bundle branch block, unchanged from prior.

Which of the following is the most appropriate next step in the management of this patient?

Continue metoprolol succinate at the current dosage

Initiate intravenous phenylephrine to improve blood pressure

Withhold the home dose of metoprolol succinate

Delay intravenous diuresis until serum potassium is repleted

Order a comprehensive echocardiogram before administering inotropes

Cevabı ve açıklamayı göster

Cevap: Withhold the home dose of metoprolol succinate

Cevap

Withhold the home dose of metoprolol succinate

This patient presents with acute decompensated heart failure manifesting as cardiogenic shock. Her clinical profile is 'cold and wet,' characterized by severe volume overload (pulmonary crackles, jugular venous distention) and significant tissue hypoperfusion (hypotension, confusion, cold/mottled extremities, delayed capillary refill). In patients with this hemodynamic profile, home beta-blockers (such as metoprolol succinate) must be immediately withheld. Their negative inotropic and chronotropic effects further depress cardiac output and exacerbate systemic hypoperfusion. The appropriate management includes withholding the beta-blocker, providing noninvasive positive pressure ventilation, administering loop diuretics (while closely monitoring hemodynamics), and initiating intravenous inotropic support (e.g., dobutamine or milrinone) to improve forward cardiac output.

Adım Adım Çözüm

Interpret the clinical presentation and vital signs.

The patient has hypotension, tachycardia, confusion, and cold/mottled extremities indicating hypoperfusion, along with crackles and elevated JVP indicating severe volume overload.

This establishes the hemodynamic profile as cardiogenic shock, specifically the 'cold and wet' phenotype of acute decompensated heart failure (ADHF).

Evaluate the patient's home medication list in the context of her hemodynamic status.

The patient takes metoprolol succinate, a beta-blocker.

Identifying home medications that are contraindicated in the acute setting is a critical step in stabilization.

Determine the appropriate pharmacologic adjustment.

The beta-blocker must be immediately withheld.

Beta-blockers have negative inotropic effects that will further depress cardiac output and exacerbate systemic hypoperfusion in cardiogenic shock.

Anahtar Kavram

Management of acute decompensated heart failure (ADHF) phenotypes, specifically recognizing cardiogenic shock ('cold and wet' profile) as an absolute indication to withhold beta-blocker therapy.

Tahmini Süre:1m 30s

Soru 1306Soru →

Determine the most appropriate care setting transition or disposition for each of the following patients based on their clinical risk stratification, functional status, and acute care needs.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Cevabı ve açıklamayı göster

Cevap

The pneumonia patient requires the ICU, the DVT patient can be discharged home, the robust stroke patient should go to an IRF, and the deconditioned pyelonephritis patient should transfer to a SNF.

Each patient's disposition aligns with clinical guidelines: objective severity scores dictate ICU for the pneumonia patient and home for the DVT patient, while functional endurance dictates IRF for the robust stroke patient and SNF for the fatigued patient.

Adım Adım Çözüm

Evaluate the patient's acute medical stability and severity of illness using objective scoring systems.

The pneumonia patient has a high CURB-65 score necessitating the ICU. The DVT patient is low-risk and stable for home.

Severity of illness dictates whether an inpatient level of care (ward vs. ICU) or outpatient management is appropriate.

Assess the functional status and physical therapy tolerance of medically stable patients requiring post-acute care.

The stroke patient can tolerate >3 hours of therapy (qualifying for IRF), whereas the deconditioned patient cannot (making SNF appropriate).

Medicare guidelines and clinical best practices differentiate IRF and SNF heavily based on the patient's capacity to participate in intensive therapy.

Anahtar Kavram

Appropriate care setting transitions rely on matching medical acuity to inpatient levels of care (e.g., CURB-65 for pneumonia) and matching functional tolerance to post-acute rehabilitation settings (IRF vs. SNF).

Soru 1307Soru →

Match each clinical presentation with the single most appropriate evidence-based screening, immunization, or preventive intervention.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Cevabı ve açıklamayı göster

Cevap

The 45-year-old man requires colorectal cancer screening; the 67-year-old former smoker requires abdominal aortic aneurysm screening; the 65-year-old woman requires pneumococcal vaccination; and the 38-year-old woman with obesity requires diabetes screening.

Appropriate preventive care requires matching patient-specific demographic factors—such as age, sex, BMI, and smoking history—with current USPSTF and ACIP guidelines. Colorectal screening universally begins at age 45. AAA screening applies to men 65-75 with any smoking history. Pneumococcal vaccines are universally indicated at age 65. Diabetes screening is indicated for overweight and obese adults starting at age 35.

Adım Adım Çözüm

Analyze the 45-year-old man's risk profile (average risk, age 45).

Matched to colorectal cancer screening.

Current USPSTF guidelines recommend lowering the initiation age for colorectal cancer screening to 45 years due to the rising incidence of early-onset disease.

Analyze the 67-year-old man's risk profile (age 65-75, any lifetime history of smoking).

Matched to one-time abdominal aortic aneurysm screening with ultrasound.

Any smoking history (≥100 cigarettes) triggers the indication for AAA screening in men reaching age 65, regardless of when they quit.

Analyze the 65-year-old woman's risk profile (age 65).

Matched to administration of a pneumococcal conjugate vaccine.

Age 65 is the universal threshold for initiating routine adult pneumococcal vaccination for individuals without high-risk immunocompromising conditions.

Analyze the 38-year-old woman's risk profile (age 35-70, BMI > 25 kg/m²).

Matched to hemoglobin A1c or fasting plasma glucose test.

USPSTF guidelines mandate type 2 diabetes screening for adults aged 35 to 70 who present with overweight or obesity.

Anahtar Kavram

Application of age- and risk-based USPSTF and ACIP preventive care guidelines across diverse adult populations.

Soru 1308Soru →

A 54-year-old man who underwent an orthotopic heart transplant six months ago is admitted to the hospital with hemoptysis, pleuritic chest pain, and a low-grade fever. His maintenance immunosuppressive regimen consists of tacrolimus, mycophenolate mofetil, and low-dose prednisone. Chest computed tomography reveals a right upper lobe dense consolidation with a surrounding halo of ground-glass opacity. Serum galactomannan testing is markedly positive, establishing a diagnosis of invasive pulmonary aspergillosis. The infectious disease service recommends initiating intravenous posaconazole therapy immediately.

Which of the following treatment modifications and monitoring strategies are indicated for this patient upon starting the antifungal therapy? (Select two)

Geçerli olan tümünü seçin

Decrease the daily dose of tacrolimus empirically.

Perform serial electrocardiograms to monitor the QTc interval.

Delay the initiation of posaconazole until a bronchoscopy with bronchoalveolar lavage confirms the diagnosis.

Defer therapeutic drug monitoring of tacrolimus until posaconazole reaches steady state.

Discontinue mycophenolate mofetil preemptively to prevent synergistic bone marrow suppression.

Cevabı ve açıklamayı göster

Cevap: Decrease the daily dose of tacrolimus empirically.; Perform serial electrocardiograms to monitor the QTc interval.

Cevap

The correct strategies are to decrease the daily dose of tacrolimus empirically and to perform serial electrocardiograms to monitor the QTc interval.

Posaconazole is a potent inhibitor of the cytochrome P450 3A4 (CYP3A4) enzyme. Tacrolimus is a calcineurin inhibitor that is heavily metabolized by CYP3A4. Coadministration leads to significantly elevated tacrolimus levels, greatly increasing the risk of acute nephrotoxicity and neurotoxicity. Standard of care requires a preemptive, empiric reduction in the tacrolimus dose (often by one-third to one-half) when starting an azole antifungal. Furthermore, both posaconazole and tacrolimus are known to cause QTc interval prolongation. Their concomitant use creates an additive risk for malignant arrhythmias, mandating serial electrocardiogram (ECG) monitoring.

Adım Adım Çözüm

Evaluate the proposed new medication (posaconazole) for pharmacokinetic interactions with the patient's current immunosuppressive regimen.

Posaconazole is identified as a strong inhibitor of the CYP3A4 enzyme, which is responsible for the metabolism of tacrolimus.

Preventing acute calcineurin inhibitor toxicity (such as severe nephrotoxicity and neurotoxicity) requires anticipating impaired clearance of the drug.

Assess for overlapping or additive toxicities between the patient's current medications and posaconazole.

Both tacrolimus and posaconazole are recognized as medications that can independently prolong the QTc interval.

Recognizing additive adverse effect profiles is crucial to prevent life-threatening arrhythmias, such as Torsades de Pointes.

Implement a safe initiation and monitoring strategy.

Empirically reduce the tacrolimus dose, start posaconazole without delay, and order serial ECGs for the duration of concurrent therapy.

This comprehensively balances the need for life-saving antifungal therapy with the severe risks of immunosuppressant toxicity and malignant arrhythmias.

Anahtar Kavram

Management of pharmacokinetic interactions and overlapping toxicities when initiating azole antifungals in solid organ transplant recipients.

Tahmini Süre:2m 0s

Soru 1309Soru →

An asymptomatic 37-year-old man presents to the outpatient clinic to establish primary care. He feels well and reports no fatigue, polyuria, or changes in vision. His medical history is unremarkable, and he takes no prescription medications. He works as a software engineer and describes his lifestyle as sedentary. He does not smoke or use illicit drugs and consumes alcohol socially. His father was diagnosed with type 2 diabetes mellitus at age 50.

Records indicate he had a normal fasting lipid panel at age 32 and a negative hepatitis C antibody test three years ago.

Vital signs show a blood pressure of 126/80 mm Hg and a heart rate of 72/min. His body mass index is 29 kg/m^2. Physical examination is unremarkable, with no acanthosis nigricans or peripheral edema.

In accordance with current preventive care guidelines, which of the following is the most appropriate screening test to perform today?

Hemoglobin A1c

Serum thyroid-stimulating hormone

Resting electrocardiography

Fecal immunochemical testing

Routine urinalysis

Cevabı ve açıklamayı göster

Cevap: Hemoglobin A1c

Cevap

Hemoglobin A1c testing should be performed because the patient is between the ages of 35 and 70 and has a BMI classified as overweight, which meets the current USPSTF criteria for diabetes screening.

This patient is a 37-year-old man with a BMI of 29 kg/m^2, which classifies him as overweight. According to the United States Preventive Services Task Force (USPSTF) guidelines (updated in 2021), clinicians should screen for prediabetes and type 2 diabetes in adults aged 35 to 70 years who are overweight or obese. Hemoglobin A1c, fasting plasma glucose, or an oral glucose tolerance test are all acceptable screening modalities. Given his age and BMI, screening is strongly indicated to identify early dysglycemia and initiate appropriate lifestyle or pharmacologic interventions. His family history of diabetes further compounds his risk, though his age and BMI alone are sufficient to trigger the recommendation.

Adım Adım Çözüm

Analyze the patient's demographic and clinical risk profile.

The patient is a 37-year-old male with a BMI of 29 kg/m^2, indicating he is overweight.

Identifying age and BMI is critical for accurately applying metabolic screening guidelines.

Evaluate the need for type 2 diabetes screening.

The patient qualifies for diabetes screening because he falls within the 35 to 70 age range and has a BMI >= 25 kg/m^2.

The USPSTF recently updated its guidelines to lower the starting age for diabetes screening from 40 to 35 for overweight and obese adults.

Rule out other routine screening modalities based on age and lack of symptoms.

Tests such as FIT, TSH, urinalysis, and ECG do not meet the criteria for routine screening in this asymptomatic 37-year-old.

Adhering to evidence-based guidelines prevents overdiagnosis, unnecessary healthcare costs, and potential harms from false positives.

Anahtar Kavram

The USPSTF recommends screening for prediabetes and type 2 diabetes in adults aged 35 to 70 years who are overweight or obese.

Soru 1310Soru →

A 70-year-old man presents to the preoperative clinic for evaluation prior to an elective right total hip arthroplasty for severe osteoarthritis. His medical history is significant for hypertension, hyperlipidemia, and a non-ST-segment elevation myocardial infarction (NSTEMI) that occurred 6 weeks ago. At that time, he underwent percutaneous coronary intervention with the placement of a drug-eluting stent (DES) in the left anterior descending artery. His current medications include aspirin, clopidogrel, metoprolol, lisinopril, and atorvastatin. He reports no chest pain or shortness of breath with his current limited daily activities. Vital signs are within normal limits. Physical examination is unremarkable except for decreased range of motion and crepitus in the right hip. Which of the following are the most appropriate recommendations regarding his surgical and perioperative management? (Select all that apply)

Geçerli olan tümünü seçin

Postpone the elective arthroplasty until at least 6 months have passed since the stent placement

When the surgery is eventually performed, continue aspirin therapy throughout the perioperative period

Discontinue clopidogrel immediately and proceed with the scheduled surgery in 7 days

Discontinue both antiplatelet agents and initiate bridging therapy with low-molecular-weight heparin

Perform a preoperative dobutamine stress echocardiogram to determine if the surgery can safely proceed next week

Cevabı ve açıklamayı göster

Cevap: Postpone the elective arthroplasty until at least 6 months have passed since the stent placement; When the surgery is eventually performed, continue aspirin therapy throughout the perioperative period

Cevap

The most appropriate recommendations are to postpone the elective surgery for at least 6 months after the stent placement and to continue aspirin therapy perioperatively when the procedure is eventually performed.

Patients who undergo percutaneous coronary intervention with a drug-eluting stent require dual antiplatelet therapy (DAPT) to prevent stent thrombosis. For patients with acute coronary syndrome, DAPT is typically indicated for 12 months. Current guidelines mandate that elective noncardiac surgery be delayed for at least 6 months after DES placement to allow for adequate endothelialization of the stent. Furthermore, when elective surgery is eventually performed, aspirin should be continued perioperatively to maintain baseline platelet inhibition, as the risk of cardiac events generally outweighs the risk of surgical bleeding.

Adım Adım Çözüm

Evaluate the urgency of the proposed surgical intervention.

The procedure is an elective total hip arthroplasty.

Elective surgeries offer flexibility in scheduling, allowing optimization of the patient's cardiovascular status prior to the procedure.

Assess the patient's recent cardiovascular history and interventions.

The patient had a drug-eluting stent (DES) placed 6 weeks ago for a non-ST-segment elevation myocardial infarction.

Recent acute coronary syndrome and DES placement are major risk factors for perioperative myocardial infarction and stent thrombosis.

Apply surgical timing guidelines for patients with recent DES placement.

Elective noncardiac surgery should be postponed for at least 6 months (and optimally 12 months following acute coronary syndrome).

Performing surgery shortly after stent placement requires premature cessation of dual antiplatelet therapy and induces a prothrombotic state, significantly increasing the risk of stent thrombosis.

Determine the optimal perioperative antiplatelet strategy when surgery is eventually performed.

Aspirin should be continued throughout the perioperative period.

Maintaining single antiplatelet therapy reduces the risk of adverse cardiac events without prohibitively increasing the risk of major surgical bleeding.

Anahtar Kavram

Perioperative cardiovascular management and timing of elective noncardiac surgery following drug-eluting stent placement.

Tahmini Süre:1m 30s

Soru 1311Soru →

A 66-year-old man is evaluated for discharge on hospital day 12. He was admitted for a severe acute exacerbation of chronic obstructive pulmonary disease (COPD) requiring intubation and mechanical ventilation. He was successfully extubated three days ago and is currently stable on 2 L/min of oxygen via nasal cannula. He is hemodynamically stable, afebrile, and his acute respiratory infection has resolved. His comorbidities include heart failure with preserved ejection fraction and type 2 diabetes mellitus. During his intensive care unit stay, he developed a new Stage 3 pressure injury on his sacrum that requires daily skilled wound care. Prior to admission, he was fully ambulatory and independent. Currently, he requires moderate assistance with all transfers and can walk only 15 feet with a walker before becoming severely dyspneic and fatigued. A physical therapy evaluation concludes that he has significant rehabilitation potential but can currently tolerate a total of only 60 to 90 minutes of therapy spread throughout the day due to cardiopulmonary limitations. Laboratory studies show a stable serum creatinine of 1.4 mg/dL (baseline 1.3 mg/dL). He lives with his elderly wife, who has severe osteoarthritis and uses a wheelchair, rendering her unable to assist him with mobility or personal care.

Which of the following is the most appropriate disposition plan for this patient?

Transfer to a skilled nursing facility

Transfer to an inpatient rehabilitation facility

Transfer to a long-term acute care hospital

Discharge home with comprehensive home health services

Retain in the acute care hospital for intravenous fluid administration until renal function normalizes

Cevabı ve açıklamayı göster

Cevap: Transfer to a skilled nursing facility

Cevap

Transfer to a skilled nursing facility

The correct disposition is transfer to a skilled nursing facility (SNF). This patient is medically stable and ready for discharge from the acute care hospital, but he has two significant ongoing needs: daily skilled wound care for a Stage 3 pressure injury and multidiciplinary rehabilitation for severe deconditioning. Because he can only tolerate 60 to 90 minutes of therapy daily, he does not qualify for an inpatient rehabilitation facility (IRF), which strictly requires the ability to participate in at least 3 hours of intensive therapy per day. Furthermore, discharging him home with home health services is unsafe; home health agencies provide intermittent skilled visits, but the patient requires ongoing custodial assistance for transfers and ADLs that his wheelchair-bound wife cannot provide. An SNF provides the appropriate combination of 24-hour custodial care, skilled nursing for wound management, and rehabilitation paced to the patient's tolerance.

Adım Adım Çözüm

Determine the patient's medical stability for discharge.

The patient is extubated, hemodynamically stable, afebrile, and his infection has resolved.

Establishing medical stability confirms the patient no longer requires acute inpatient hospital care and is ready for post-acute disposition.

Assess the patient's functional status, skilled care needs, and therapy tolerance.

The patient requires daily skilled wound care for a Stage 3 pressure injury and physical therapy, but can only tolerate 60 to 90 minutes of therapy per day.

Specific post-acute care facilities have strict admission criteria based on therapy tolerance and medical needs.

Evaluate the safety and feasibility of a home discharge.

Home discharge is deemed unsafe because the patient requires moderate assistance with transfers and his wife is physically unable to assist him.

Home health services only provide intermittent care; 24-hour safety and custodial support must be available from family for a safe home discharge in a highly dependent patient.

Select the appropriate care setting based on the synthesized criteria.

A skilled nursing facility (SNF) is selected.

SNFs accommodate patients who need daily skilled nursing and therapy but cannot meet the 3-hour daily intensive therapy requirement of an inpatient rehabilitation facility (IRF).

Anahtar Kavram

Appropriate disposition for post-acute care requires matching the patient's medical stability, physical therapy tolerance (e.g., 3-hour minimum for IRF), skilled nursing needs, and available home caregiver support to strict facility criteria.

Soru 1312Soru →

A $58$ -year-old man is admitted to the hospital with a $2$ -day history of diffuse abdominal pain, fever, and confusion. He has a history of decompensated alcohol-associated cirrhosis. His current medications include furosemide, spironolactone, and nadolol. Temperature is $38.1^\circ\text{C}$ ( $100.6^\circ\text{F}$ ), blood pressure is $96/60\text{ mm Hg}$ , pulse is $102/\text{min}$ , and respirations are $18/\text{min}$ . Physical examination reveals scleral icterus, spider angiomata, and a distended, diffusely tender abdomen with shifting dullness. Mild asterixis is present.

Laboratory results:
Hemoglobin: $10.2\text{ g/dL}$
Platelet count: $88,000/\text{mm}^3$
Leukocyte count: $11,500/\text{mm}^3$
Blood urea nitrogen: $36\text{ mg/dL}$
Serum creatinine: $1.8\text{ mg/dL}$ (baseline $1.0\text{ mg/dL}$ )
Total bilirubin: $3.4\text{ mg/dL}$
INR: $1.7$

Diagnostic paracentesis yields cloudy ascitic fluid with a polymorphonuclear leukocyte count of $650/\text{mm}^3$ . Intravenous cefotaxime is initiated, and his home medications are temporarily withheld. Which of the following is the most appropriate additional pharmacologic intervention at this time?

Intravenous albumin

Intravenous fresh frozen plasma

Intravenous vancomycin

Oral propranolol

Oral rifaximin

Cevabı ve açıklamayı göster

Cevap: Intravenous albumin

Cevap

Intravenous albumin

The correct answer is intravenous albumin. This patient has spontaneous bacterial peritonitis (SBP), diagnosed by an ascitic fluid PMN count

>250/\text{mm}^3

. While empiric antibiotic therapy (e.g., third-generation cephalosporin like cefotaxime) is the crucial first step, patients with SBP are at significant risk for developing hepatorenal syndrome (HRS) due to systemic vasodilation and reduced effective arterial blood volume. The risk of HRS and mortality is highest in patients with preexisting or concurrent renal dysfunction. Guidelines strictly recommend the administration of intravenous albumin (

1.5\text{ g/kg}

on day 1, and

1.0\text{ g/kg}

on day 3) for SBP patients who meet any of the following criteria: serum creatinine

>1.0\text{ mg/dL}

, blood urea nitrogen

>30\text{ mg/dL}

, or total bilirubin

>4.0\text{ mg/dL}

. This patient meets the criteria with a creatinine of

1.8\text{ mg/dL}

and BUN of

36\text{ mg/dL}

. Albumin provides prolonged oncotic support, improving renal perfusion and significantly reducing the incidence of HRS and short-term mortality.

Adım Adım Çözüm

Diagnose the acute condition based on clinical presentation and ascitic fluid analysis.

The patient has spontaneous bacterial peritonitis (SBP), confirmed by an ascitic fluid polymorphonuclear leukocyte (PMN) count

>250/\text{mm}^3

Accurate diagnosis is required to initiate the correct standard-of-care protocol.

Assess the patient's renal function and hemodynamic status.

The patient has acute kidney injury (AKI) with a serum creatinine of

1.8\text{ mg/dL}

(baseline

1.0\text{ mg/dL}

), an elevated BUN of

36\text{ mg/dL}

, and borderline hypotension.

Renal impairment in the setting of SBP places the patient at high risk for developing hepatorenal syndrome (HRS).

Determine the necessary pharmacologic interventions beyond empiric antibiotics.

In addition to cefotaxime, the administration of intravenous albumin is indicated.

Guidelines recommend IV albumin for SBP patients with Cr

>1.0\text{ mg/dL}

, BUN

>30\text{ mg/dL}

, or total bilirubin

>4.0\text{ mg/dL}

to expand effective circulating volume and prevent HRS.

Anahtar Kavram

Patients with spontaneous bacterial peritonitis (SBP) who have concurrent renal dysfunction (creatinine

>1.0\text{ mg/dL}

or BUN

>30\text{ mg/dL}

) require intravenous albumin supplementation in addition to antibiotics to prevent hepatorenal syndrome and reduce mortality.

Soru 1313Soru →

A 78-year-old woman is evaluated in the intensive care unit for new-onset fever and abdominal pain. She was admitted 5 days ago for a massive anterior ST-segment elevation myocardial infarction complicated by cardiogenic shock. She currently remains on a dobutamine infusion for hemodynamic support. Over the past 12 hours, her temperature has risen to 39.2°C (102.6°F) and she has developed significant right upper quadrant abdominal tenderness. Her blood pressure is 88/56 mm Hg and pulse is 115/min. Laboratory studies show a leukocyte count of 18,500/mm³ with a left shift. Liver function tests reveal normal total bilirubin and alkaline phosphatase levels. A bedside right upper quadrant ultrasound demonstrates gallbladder wall thickening of 6 mm, pericholecystic fluid, and a positive sonographic Murphy sign. No gallstones or common bile duct dilation are visualized. Intravenous broad-spectrum antibiotics are initiated. Which of the following is the most appropriate next step in the management of this patient?

Percutaneous cholecystostomy tube placement

Emergent laparoscopic cholecystectomy

Hepatobiliary iminodiacetic acid (HIDA) scan

Endoscopic retrograde cholangiopancreatography (ERCP)

Continuation of current medical management and close observation

Cevabı ve açıklamayı göster

Cevap: Percutaneous cholecystostomy tube placement

Cevap

Percutaneous cholecystostomy tube placement is the most appropriate next step for this critically ill patient with acute acalculous cholecystitis.

The correct intervention is percutaneous cholecystostomy tube placement. This patient has developed acute acalculous cholecystitis (AAC), a severe inflammation of the gallbladder without gallstones that typically occurs in critically ill, hospitalized patients (e.g., those with recent surgery, trauma, burns, or prolonged shock). The diagnosis is confirmed clinically by fever, leukocytosis, and right upper quadrant pain, combined with ultrasound findings of gallbladder wall thickening and pericholecystic fluid. Source control is mandatory because AAC progresses rapidly to gallbladder gangrene and perforation. While laparoscopic cholecystectomy is the definitive treatment for acute cholecystitis, this patient is in cardiogenic shock on dobutamine following a massive myocardial infarction, making her a prohibitively high surgical risk. Percutaneous cholecystostomy provides rapid, minimally invasive biliary decompression and source control without the need for general anesthesia.

Adım Adım Çözüm

Analyze the patient's clinical presentation and ultrasound findings.

The patient has fever, leukocytosis, right upper quadrant pain, and ultrasound findings of gallbladder inflammation without stones, confirming the diagnosis of acute acalculous cholecystitis.

Establishing the correct diagnosis is the first step in determining appropriate management.

Assess the patient's surgical risk.

The patient is recovering from a massive myocardial infarction and is in active cardiogenic shock requiring dobutamine.

Surgical risk stratification determines whether a patient can safely undergo a definitive surgical procedure like a cholecystectomy.

Determine the appropriate intervention based on surgical risk.

Because the surgical risk is prohibitively high, a minimally invasive percutaneous drainage procedure must be selected to achieve necessary source control.

Untreated acalculous cholecystitis is rapidly fatal due to gangrene and perforation; if surgery is contraindicated, percutaneous cholecystostomy is the standard of care.

Anahtar Kavram

Acute acalculous cholecystitis typically occurs in critically ill patients (e.g., sepsis, trauma, cardiogenic shock). Because these patients are usually poor surgical candidates, the treatment of choice is antibiotics and percutaneous cholecystostomy.

Tahmini Süre:1m 15s

Soru 1314Soru →

A 45-year-old man is evaluated by the multidisciplinary care team for discharge planning on hospital day 12. He was originally admitted after sustaining a traumatic brain injury and multiple rib fractures in a motor vehicle collision. His hospital course was initially complicated by a brief period of mechanical ventilation, but he was extubated on day 4 and is currently medically stable. Vital signs are within normal limits. On physical examination, the patient is alert and oriented to person, place, and time. He has residual right-sided hemiparesis, with motor strength of 3/5 in the right upper and lower extremities. His swallowing function is intact. A physical therapy evaluation demonstrates that he requires moderate assistance with bed-to-chair transfers and ambulation. The patient is highly motivated and successfully participated in a combined total of 3.5 hours of physical, occupational, and speech therapy yesterday without excessive fatigue. His wife is supportive and plans to take a leave of absence from work to assist him, but they live in a two-story home with bedrooms on the second floor. Which of the following is the most appropriate disposition for this patient?

Inpatient rehabilitation facility

Skilled nursing facility

Long-term acute care hospital

Home with home health services

Continued acute care hospital admission

Cevabı ve açıklamayı göster

Cevap: Inpatient rehabilitation facility

Cevap

Inpatient rehabilitation facility

The correct disposition is an inpatient rehabilitation facility (IRF). IRFs are designed for medically stable patients who require intensive, multidisciplinary rehabilitation (such as physical, occupational, and speech therapy) and can tolerate at least 3 hours of therapy per day. This patient has significant functional deficits due to his traumatic brain injury but is highly motivated and has explicitly demonstrated the ability to participate in 3.5 hours of therapy without excessive fatigue.

Adım Adım Çözüm

Assess the patient's medical stability and current acuity.

The patient is medically stable, extubated, and has normal vital signs, ruling out the need for continued acute care or long-term acute care (LTACH).

Determining medical stability is the crucial first step in care transition planning.

Evaluate the patient's functional status, safety, and therapy needs.

The patient has significant neurological deficits (hemiparesis), requires moderate assistance with transfers, and lives in a two-story home, making an immediate transition to home unsafe.

Ensuring a safe discharge environment prevents readmissions and patient harm.

Determine the appropriate level of post-acute rehabilitation based on therapy tolerance.

The patient successfully participated in 3.5 hours of multidisciplinary therapy, indicating he can tolerate the rigorous requirements of an inpatient rehabilitation facility (IRF).

Matching the patient's functional capacity and therapy tolerance to the correct facility level ensures optimal recovery.

Anahtar Kavram

Appropriate disposition for post-acute rehabilitation depends heavily on the patient's medical stability and ability to tolerate intensive therapy (at least 3 hours per day for an IRF versus less intensive therapy in a SNF).

Soru 1315Soru →

A 78-year-old man is being prepared for discharge after a 12-day hospitalization for urosepsis. Upon admission, his temperature was 38.9°C (102.0°F), blood pressure was 85/50 mm Hg, and serum creatinine was 3.2 mg/dL. He responded well to intravenous fluids and antibiotics; current vitals are temperature 37.1°C (98.8°F), blood pressure 122/76 mm Hg, and heart rate 78/min. His serum creatinine has improved to 1.8 mg/dL. Despite medical stabilization, his functional status has declined, requiring the assistance of two people for transfers. Furthermore, his cognitive status continues to fluctuate with new-onset delirium, and a formal assessment reveals he currently lacks medical decision-making capacity. The care team is initiating the discharge process. Arrange the following critical steps in this patient's transition of care in the most appropriate chronological order to ensure a safe, legally sound, and comprehensive disposition.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence is: 1) Identify the surrogate decision-maker, 2) Determine the post-acute care setting, 3) Perform medication reconciliation, 4) Finalize the discharge summary, and 5) Execute a verbal provider-to-provider handoff.

A safe and legally sound transition of care for an incapacitated patient follows a structured sequence: First, the legally authorized surrogate must be identified to provide consent. Second, the appropriate care setting is determined collaboratively with the surrogate. Third, medication reconciliation is performed to tailor the pharmacologic plan to the patient's current physiologic state and the new setting. Fourth, these plans are formalized into a comprehensive written discharge summary. Finally, a synchronous verbal handoff is conducted to ensure closed-loop communication with the receiving providers.

Adım Adım Çözüm

Assess the patient's capacity and legal framework.

Identification of the surrogate decision-maker.

The patient's delirium impairs capacity, meaning legal consent for discharge planning must come from the authorized surrogate.

Collaborate on disposition planning.

Determination of the post-acute care setting.

The surrogate and multidisciplinary team must agree on the discharge location based on the patient's severe functional decline.

Optimize medical therapy for discharge.

Comprehensive medication reconciliation.

Medications must be adjusted for the patient's improving but still impaired renal function and the formulary capabilities of the receiving setting before finalizing discharge orders.

Document the transition plan.

Finalization of the discharge summary.

A comprehensive written document detailing the hospital course, reconciled medications, and pending tests is essential for continuity of care.

Communicate the plan to the receiving team.

Synchronous verbal handoff.

Direct communication resolves ambiguities and ensures the receiving facility is fully prepared for the transfer.

Anahtar Kavram

Standardized transition of care protocol for incapacitated patients

Tahmini Süre:1m 30s

Soru 1316Soru →

A $34$ -year-old female is evaluated in the emergency department after experiencing the abrupt onset of severe, cramping periumbilical pain radiating to her back $6$ hours ago. She has also had multiple episodes of bilious vomiting. Her medical history is significant for morbid obesity, for which she underwent an uncomplicated laparoscopic Roux-en-Y gastric bypass $4$ years ago. Her current body mass index is $26 \text{ kg/m}^2$ . Her temperature is $37.1^\circ\text{C}$ ( $98.8^\circ\text{F}$ ), blood pressure is $112/68 \text{ mm Hg}$ , pulse is $118/\text{min}$ , and respirations are $20/\text{min}$ . Physical examination reveals a non-distended but diffusely tender abdomen, particularly in the periumbilical region, with mild voluntary guarding. Bowel sounds are high-pitched and hyperactive. Laboratory studies show a leukocyte count of $14,200/\text{mm}^3$ and a serum lactate level of $3.1 \text{ mmol/L}$ . A computed tomography scan of the abdomen and pelvis with intravenous contrast reveals small bowel dilation with a transition point and a 'swirl sign' of the mesenteric vessels. Which of the following is the most appropriate next step in management?

Urgent upper gastrointestinal endoscopy

Nasogastric tube placement and serial abdominal examinations

Administration of intravenous metoclopramide

Emergent surgical exploration

Repeat computed tomography scan of the abdomen and pelvis with oral contrast

Cevabı ve açıklamayı göster

Cevap: Emergent surgical exploration

Cevap

Emergent surgical exploration

The correct answer is emergent surgical exploration. This patient is presenting with a small bowel obstruction complicated by suspected bowel ischemia (indicated by tachycardia, leukocytosis, and an elevated serum lactate), most likely due to an internal hernia. Patients with a history of Roux-en-Y gastric bypass are at high risk for internal hernias because the surgical restructuring creates unnatural mesenteric defects (e.g., Petersen's space, mesojejunal defect) through which the small bowel can herniate. The 'swirl sign' on computed tomography imaging represents twisted mesenteric vessels and is a highly specific indicator of an internal hernia with a closed-loop obstruction. Because closed-loop obstructions rapidly progress to strangulation, irreversible ischemia, and necrosis, immediate operative intervention (diagnostic laparoscopy or exploratory laparotomy) is absolutely necessary to reduce the herniated bowel, assess its viability, and close the mesenteric defects.

Adım Adım Çözüm

Evaluate the patient's history and acute presentation.

The patient has a history of Roux-en-Y gastric bypass and presents with severe abdominal pain, bilious vomiting, tachycardia, leukocytosis, and elevated lactate.

These findings are highly suspicious for a surgical abdomen, particularly bowel ischemia.

Interpret the imaging findings in the context of her surgical history.

The CT scan shows a 'swirl sign' of the mesenteric vessels and a small bowel transition point, confirming a closed-loop obstruction due to an internal hernia.

Roux-en-Y gastric bypass creates mesenteric defects that predispose patients to internal hernias, which often present as closed-loop obstructions.

Determine the appropriate intervention.

The patient requires emergent surgical exploration.

Closed-loop obstructions with signs of ischemia (elevated lactate, leukocytosis) carry a high mortality rate if definitive surgical reduction is delayed.

Anahtar Kavram

Recognition and immediate surgical management of an internal hernia presenting as a closed-loop obstruction in a patient with a history of Roux-en-Y gastric bypass.

Soru 1317Soru →

A community health center is initiating a quality improvement protocol to address gaps in age-appropriate and risk-appropriate preventive services. Based on current United States Preventive Services Task Force (USPSTF) guidelines, match each patient profile with the single most urgently indicated screening intervention.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Cevabı ve açıklamayı göster

Cevap

The 52-year-old woman requires mammography (due for biennial screening), the 66-year-old man requires a colonoscopy (11 years since his last exam), the 70-year-old former smoker requires LDCT (meets age, pack-year, and quit-date criteria), and the 28-year-old pregnant woman requires a urine culture for asymptomatic bacteriuria.

Each patient has exactly one outstanding, guideline-directed preventive screening need based on their demographic and clinical profile. Identifying the correct intervention requires knowing the specific start ages, stop ages, screening intervals, and risk-based modifications (such as smoking history or pregnancy) for USPSTF Grade A and B recommendations.

Adım Adım Çözüm

Evaluate the 52-year-old woman's preventive care needs.

She requires bilateral screening mammography.

Her last mammogram was 3 years ago. Current guidelines recommend biennial mammography starting at age 40.

Evaluate the 66-year-old man's preventive care needs.

He requires a screening colonoscopy.

His last colonoscopy was 11 years ago, which exceeds the standard 10-year interval for average-risk individuals.

Evaluate the 70-year-old man's preventive care needs.

He requires low-dose computed tomography (LDCT) of the chest.

He falls within the 50-80 age range, has at least a 20 pack-year history, and quit within the last 15 years.

Evaluate the 28-year-old pregnant woman's preventive care needs.

She requires a urine culture for asymptomatic bacteriuria.

Routine screening for asymptomatic bacteriuria is standard at the first prenatal visit to prevent adverse maternal and fetal outcomes.

Anahtar Kavram

Application of age-appropriate, gender-appropriate, and risk factor-based USPSTF preventive screening guidelines.

Soru 1318Soru →

A 42-year-old woman is evaluated in the clinic for a scheduled 4-week follow-up visit. One month ago, she was diagnosed with latent tuberculosis infection after a positive interferon-gamma release assay during a routine occupational health screening. She was started on a 9-month course of daily isoniazid and pyridoxine. Today, the patient reports perfect adherence to her medication regimen. She feels well and specifically denies fatigue, anorexia, nausea, vomiting, right upper quadrant pain, or dark-colored urine. She has no history of liver disease and takes no other medications. She does not consume alcohol.

Vital signs are within normal limits. Physical examination reveals anicteric sclerae and a soft, non-tender abdomen with no palpable hepatomegaly.

Laboratory studies show:
Alanine aminotransferase (ALT): 115 U/L (Reference: 7–52 U/L)
Aspartate aminotransferase (AST): 98 U/L (Reference: 10–40 U/L)
Alkaline phosphatase: 80 U/L (Reference: 40–120 U/L)
Total bilirubin: 0.9 mg/dL (Reference: 0.1–1.2 mg/dL)

Which of the following is the most appropriate next step in the management of this patient?

Continue the current medication regimen and repeat liver function tests in 2 to 4 weeks

Discontinue isoniazid and initiate rifampin monotherapy

Suspend isoniazid therapy and obtain an abdominal ultrasound

Continue isoniazid and add rifampin to shorten the treatment course

Discontinue isoniazid and admit the patient to the hospital for observation

Cevabı ve açıklamayı göster

Cevap: Continue the current medication regimen and repeat liver function tests in 2 to 4 weeks

Cevap

Continue the current medication regimen and repeat liver function tests in 2 to 4 weeks

The correct answer is to continue the current medication regimen and repeat liver function tests. Isoniazid commonly causes a mild, self-limited asymptomatic elevation in aminotransferases (transaminitis) in up to 20% of patients. Clinical guidelines dictate that isoniazid should only be discontinued if aminotransferase levels exceed 5 times the upper limit of normal (ULN) in an asymptomatic patient, or if they exceed 3 times the ULN in a patient experiencing symptoms of hepatotoxicity (e.g., fatigue, nausea, abdominal pain, jaundice). Because this patient is completely asymptomatic and her transaminase levels are less than 3 times the ULN, continuing the medication and providing close laboratory monitoring is the standard of care.

Adım Adım Çözüm

Evaluate the patient's clinical presentation and medication history.

The patient is asymptomatic and taking isoniazid for latent tuberculosis infection.

Identifying symptoms of hepatotoxicity is critical for determining the correct threshold for drug discontinuation.

Analyze the laboratory results against standard reference ranges.

ALT is approximately 2.2 times the upper limit of normal (ULN), and AST is approximately 2.45 times the ULN. Bilirubin and alkaline phosphatase are normal.

Calculating the magnitude of transaminase elevation directs the application of drug toxicity management guidelines.

Apply established guidelines for isoniazid-induced hepatotoxicity.

The criteria to stop isoniazid (elevation > 5x ULN if asymptomatic, or > 3x ULN if symptomatic) are not met.

Since the patient is asymptomatic and elevations are mild (< 3x ULN), the standard of care is to continue the medication and monitor.

Anahtar Kavram

Management of isoniazid-induced hepatotoxicity involves continuing the drug and monitoring if transaminases are elevated but remain less than 5 times the upper limit of normal in asymptomatic patients, or less than 3 times the upper limit of normal in symptomatic patients.

Tahmini Süre:1m 30s

Soru 1319Soru →

A 62-year-old man is recovering on the general medical floor after a three-week hospitalization for severe sepsis secondary to ascending cholangitis. He initially required vasopressor support and mechanical ventilation but is now hemodynamically stable, afebrile, and breathing comfortably on room air. Due to significant intensive care unit-acquired weakness, he cannot perform basic activities of daily living independently. The primary internal medicine team determines that he requires transfer to a skilled nursing facility (SNF) for comprehensive physical and occupational therapy prior to returning home.

Arrange the following essential steps of this care transition process in the most appropriate chronological sequence to ensure patient safety and minimize the risk of readmission.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence is: Document medical stability and specific needs, followed by collaborating to secure authorization and a bed, then performing final medication reconciliation and transfer orders, and finally conducting a structured verbal handoff while transmitting the discharge summary.

Safe and effective care transitions require a standardized, sequential approach to minimize errors. The process must begin with the physician establishing medical readiness and documenting specific post-acute needs. This clinical documentation is strictly required by case management to secure insurance authorization and confirm bed placement at an appropriate facility. Only after the specific destination is confirmed should the final medication reconciliation and transfer orders be generated, ensuring the regimen is accurate and actionable for that specific SNF. Finally, a structured verbal handoff and the transmission of the written discharge summary occur just prior to physical transfer to ensure the receiving team has the most up-to-date, finalized information.

Adım Adım Çözüm

Determine readiness and specific needs.

The physician documents that the patient is medically stable but requires SNF-level physical therapy for ICU-acquired weakness.

Clear clinical documentation is the prerequisite for initiating the disposition planning process.

Secure facility placement and authorization.

Case management uses the documentation to obtain payer authorization and reserves a bed at an appropriate SNF.

Transfer orders cannot be finalized until a specific receiving destination is confirmed and authorized.

Finalize the medical transition plan.

The physician performs medication reconciliation, stopping acute hospital medications (e.g., DVT prophylaxis injections if transitioning to oral) and writes the formal transfer orders.

The receiving facility requires an accurate, finalized set of orders to safely admit the patient and administer medications immediately upon arrival.

Execute the clinical handoff.

The primary team provides a structured verbal report to the SNF staff and transmits the comprehensive discharge summary.

Direct communication of the finalized plan prevents continuity of care errors during the vulnerable transition period.

Anahtar Kavram

Standardized Care Transitions and Disposition Planning

Tahmini Süre:1m 15s

Soru 1320Soru →

A 71-year-old man presents to the primary care clinic reporting intense pain and swelling in his right big toe that began abruptly overnight. He states the pain is so severe that he cannot bear weight on his foot or tolerate the touch of a bedsheet. His medical history is significant for ischemic cardiomyopathy with a left ventricular ejection fraction of $30\%$ , stage 4 chronic kidney disease with a baseline estimated glomerular filtration rate of $24 \text{ mL/min/1.73 m}^2$ , and a hospitalized episode of bleeding peptic ulcer disease three years ago. His current daily medications include carvedilol, sacubitril-valsartan, and low-dose aspirin. Vital signs are temperature $37.2^\circ\text{C}$ ( $99.0^\circ\text{F}$ ), blood pressure $118/76\text{ mmHg}$ , and heart rate $78\text{/min}$ . Physical examination reveals a markedly erythematous, warm, swollen, and exquisitely tender first metatarsophalangeal joint on the right foot. The remainder of the joint examination is unremarkable. Which of the following is the most appropriate initial pharmacologic intervention for this patient's acute joint pain?

Intra-articular triamcinolone

Oral indomethacin

Oral colchicine

Oral prednisone

Oral allopurinol

Cevabı ve açıklamayı göster

Cevap: Intra-articular triamcinolone

Cevap

Intra-articular triamcinolone is the most appropriate initial therapy because it provides targeted relief for a monoarticular flare while bypassing the severe systemic risks associated with other agents in a patient with chronic kidney disease, heart failure, and prior peptic ulcer disease.

Intra-articular glucocorticoid injection (e.g., triamcinolone) is the safest and most effective treatment for an acute gout flare localized to 1 or 2 easily accessible joints (such as the first metatarsophalangeal joint) in patients with multiple medical comorbidities. This patient has stage 4 chronic kidney disease, severe heart failure with reduced ejection fraction, and a history of peptic ulcer disease. These conditions present absolute or severe relative contraindications to all first-line systemic therapies for acute gout. Local administration provides rapid anti-inflammatory action within the joint space while minimizing systemic absorption, thereby avoiding nephrotoxicity, fluid retention, and gastrointestinal irritation.

Adım Adım Çözüm

Diagnose the acute condition based on the clinical presentation.

The patient has acute monoarticular arthritis of the first metatarsophalangeal joint (podagra), which is classic for an acute gout flare.

Establishing the acute problem is required before selecting pharmacotherapy.

Review the patient's medical history for contraindications to standard gout therapies.

The patient has stage 4 chronic kidney disease, ischemic cardiomyopathy with a severely reduced ejection fraction, and a history of peptic ulcer bleeding.

Gout medications have strict contraindications that are frequently tested. Comorbidities dictate the safe treatment path.

Evaluate the safety profile of each pharmacological option against the identified comorbidities.

NSAIDs and colchicine are unsafe due to renal impairment and bleeding risk. Systemic steroids are unsafe due to the severe heart failure. Intra-articular steroids remain the only safe option.

To select the single best intervention by process of elimination.

Anahtar Kavram

Management of acute gout in patients with multiple comorbidities often requires localized therapy (intra-articular glucocorticoids) to avoid the systemic contraindications of NSAIDs, colchicine, and oral glucocorticoids.

Tahmini Süre:1m 15s

ÖncekiSayfa 66 / 104Sonraki

Patient Management

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram